Profile
Dear Fellow Members,
we have a new company to profile tonight that could be very attractive to many of our subscribers.
Our new profiled company is:
HEME is trading at around 3 cents and is up almost 100% since its 52 weeks low.
HEME used to trade over 30 cents!
At these levels, we believe HEME could be a huge bounce play!
HEME recently made announcements that Google and Facebook are supporting HEME ' softwares!
Those are huge industry players that are supporting Virtual and Neuro Vintage , softwares developed by HEME !
HEME also received an 86 cents price target from research firm Cohen Independent Research Group Inc.
These 2 factors alone could be a sign that HEME is very undervalued!
Coming off its 52 weeks low, we think HEME could hold tremendous upside potential!
About Healthmed Services Ltd (OTC: HEME)
http://www.healthmedltd.com/
Healthmed Services Ltd was formed in 2000. Since inception, the objective of the company has been to utilize communications technology to provide individuals, companies and health-provider organizations optimal products and services to increase the productivity and efficiency of professionals in the healthcare industry.
HEME has 2 main products Virtual Vintage and Neuro Vintage;
Virtual Vantage:
HEME has created remote access client software, namely Virtual Vantage, which allows the iPad device to communicate directly with a computer.
This product will allow records to be electronically created and stored. It will also reduce the required manpower for pushing paper, which will create an environment for more accurate record keeping, thus decreasing lawsuits in a litigious society.
Basically it permits clinics and hospital to efficiently follow-up patients in their facilities.
According to HEME , the Company anticipates that the phenomenal sales of Apple's iPad will be the driving force of software sales for products like Virtual Vantage.
Wall Street analysts recently reported iPad sales expectations of 28 million by 2011 and 57 million by 2015.
Healthcare Information Technology studies reveal 20% of healthcare professionals plan to incorporate the iPad into their practice.
$1 Billion in Ipad were already sold this year!
And according to Morgan Stanley, the projection is for over 16 million units sold this year alone!
Wall Street analysts recently reported iPad sales expectations of 28 million by 2011 and 57 million by 2015.
Clearly, the market is very receptive to the Ipad and HEME could be riding a new technological waves with the use of Virtual Vintage through the Ipad!
Neuro Vantage:
Neural Communicator (Neuro Vantage) has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate.
The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
There are five basic modules:
Speech module - text input for speech replacement;
GSM module - send and receive SMS;
MSN module;
Windows Live Messenger chat Book Reader - reading books by speech synthesis;
Web Browsing - special plug-ins for Bing Maps and Facebook.
Currently there is roughly 650 million people, live with a disability.
http://www.disabled-world.com/disability/statistics/#ixzz15kuIUSaf
HEME could be able to tap into this market and help the millions of people who needs help with their disability.
In addition, Neuro Vantage, based on plug-in architecture, will allow internet users with physical disabilities to utilize Facebook.
HEME feels this is a milestone as Facebook is used by 500 million people in 70 different languages.
Never before have disabled individuals been able to neurally communicate and interact with a platform such as Facebook.
To learn more about HEME 's products check out their website and latest press releases under these links:
http://www.healthmedltd.com/
http://finance.yahoo.com/q/h?s=HEME.PK+Headlines
The need for healthcare services is ever growing in the States.
Below are some facts on the industry that could be very positive for HEME .
• President Obama has pledged 630 billion dollars to the healthcare industry in an attempt to overhaul, modernize and transform the industry. This means hospitals and healtcare firms will have more budget to spend for better services which could mean mroe revenue for HEME !
• In fact, it is expected that healthcare spending in general could reach 4.5 trillion by 2019.
• Healthcare Information Technology studies reveal 20% of healthcare professionals plan to incorporate the iPad into their practice. This could be huge for HEME considering that one of their software can be incorporated with the Ipad!
• According to Juniper Research, spending on mobile hardware, software and services across the global healthcare sector is set to rise to $2.7 billion by 2010.
• Analysts also reveal nearly $2.5 trillion in healthcare spent in 2009 was $134 billion more than the previous year
• According to Compass Intelligence, the U.S. market for health information technology will expand to $85 billion in 2014 from an estimated $73.1 billion this year, representing a 4.5 percent compound annual growth rate.
Clearly the industry in which HEME is operating is booming and there is an ever growing need for healthcare services!
Check out the chart on HEME below.
http://www.profitspi.com/stock-chart.aspx?id=HEME&ca=1024485986
You will notice that HEME just bounced off its 52 weeks low.
This could be a reversal sign that HEME is starting an uptrend!
The chart also shows that HEME traded above 30 cents which could leave a lot of upside potential!
Check out the latest press releases from HEME for the latest updates.
http://finance.yahoo.com/q/h?s=HEME.PK+Headlines
You will notice that there was several major announcements from HEME that could have been overlooked by Wall Street!
We think this could be a great opportunity for our members to look over HEME as a potential bounce and undervalued play.
**************************************************************************
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Pennystocksalerts.com's sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Pennystocksalerts.com or an offer or solicitation to buy or sell any security. Neither the owner of Pennystocksalerts.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters . Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit Pennystocksalerts.com. Pennystocksalerts.com make s no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Please be advised that Pennystocksalerts.com has entered into an agreement with Heiwa International Corp.which calls for payment of $100,000 cash to perform promotional and advertising services for a one week profile of Healthmed Services, Ltd.(OTC:HEME) which services include the issuance of this release and the other opinions that we release concerning HEME. Pennystocksalerts.com has not investigated the background of Heiwa International Corp., the hiring company. Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of Mercer Gold Corp. (OTC:HEME) of which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price. Pennystocksalerts.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution ex penses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Healthmed Services, Ltd.(OTC:HEME). Pennystocksalerts.com is owned by: Golden Dragon Media Inc, 770 sherbrooke ouest Suite 1700, H3A 1G1, Montreal (Quebec), Canada. Questions regarding this release may be sent to info@ Pennystocksalerts.com.
Notice of Stock Price Movements and Volatility
Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.
Notice of Affiliated and Non-Affiliated Newsletters
Pennystocksalerts.com regularly shares research with two affiliated newsletters (“Affiliated Newsletters”) whose services have been retained to profile Healthmed Services Ltd “HEME” during Pennystocksalerts.com’s profile period. Pennystocksalerts regularly coordinates the timing of the dissemination of its research reports with the two Affiliated Newsletters. It is also possible that other newsletters or profiles have been created by sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in Healthmed Services Ltd “HEME”.
Some of the content in this release contains f orward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look f orward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any f orward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirem ents in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.
Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. More information can be received from the advertised companies' website http://www.healthmedltd.com/ Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and t he Financial Industry Regulatory Authority ("FINRA") website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. Pennystocksalerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Pennystocksalerts.com has no obligation to update any of the information provided. Pennystocksalerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.
From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. Pennystocksalerts.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is bas ed on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.
This release may provide hyperlinks to third party websites or access to third party content. Pennystocksalerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Pennystocksalerts.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Pennystocksalerts.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Pennystocksalerts.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
Pennystocksalerts.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.
You agree to hold Pennystocksalerts.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. Pennystocksalerts.com disclaims all warranties of any kind, express or implied.
We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm.
we have a new company to profile tonight that could be very attractive to many of our subscribers.
Our new profiled company is:
Healthmed Services Ltd. (OTC: HEME )
HEME is trading at around 3 cents and is up almost 100% since its 52 weeks low.
HEME used to trade over 30 cents!
At these levels, we believe HEME could be a huge bounce play!
HEME recently made announcements that Google and Facebook are supporting HEME ' softwares!
Those are huge industry players that are supporting Virtual and Neuro Vintage , softwares developed by HEME !
HEME also received an 86 cents price target from research firm Cohen Independent Research Group Inc.
These 2 factors alone could be a sign that HEME is very undervalued!
Coming off its 52 weeks low, we think HEME could hold tremendous upside potential!
We urge our members to put HEME on their radar and to start their Due Dilligence!
About Healthmed Services Ltd (OTC: HEME)
http://www.healthmedltd.com/
Healthmed Services Ltd was formed in 2000. Since inception, the objective of the company has been to utilize communications technology to provide individuals, companies and health-provider organizations optimal products and services to increase the productivity and efficiency of professionals in the healthcare industry.
HEME has 2 main products Virtual Vintage and Neuro Vintage;
Virtual Vantage:
HEME has created remote access client software, namely Virtual Vantage, which allows the iPad device to communicate directly with a computer.
This product will allow records to be electronically created and stored. It will also reduce the required manpower for pushing paper, which will create an environment for more accurate record keeping, thus decreasing lawsuits in a litigious society.
Basically it permits clinics and hospital to efficiently follow-up patients in their facilities.
According to HEME , the Company anticipates that the phenomenal sales of Apple's iPad will be the driving force of software sales for products like Virtual Vantage.
Wall Street analysts recently reported iPad sales expectations of 28 million by 2011 and 57 million by 2015.
Healthcare Information Technology studies reveal 20% of healthcare professionals plan to incorporate the iPad into their practice.
$1 Billion in Ipad were already sold this year!
And according to Morgan Stanley, the projection is for over 16 million units sold this year alone!
Wall Street analysts recently reported iPad sales expectations of 28 million by 2011 and 57 million by 2015.
Clearly, the market is very receptive to the Ipad and HEME could be riding a new technological waves with the use of Virtual Vintage through the Ipad!
Neuro Vantage:
Neural Communicator (Neuro Vantage) has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate.
The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
There are five basic modules:
Speech module - text input for speech replacement;
GSM module - send and receive SMS;
MSN module;
Windows Live Messenger chat Book Reader - reading books by speech synthesis;
Web Browsing - special plug-ins for Bing Maps and Facebook.
Currently there is roughly 650 million people, live with a disability.
http://www.disabled-world.com/disability/statistics/#ixzz15kuIUSaf
HEME could be able to tap into this market and help the millions of people who needs help with their disability.
In addition, Neuro Vantage, based on plug-in architecture, will allow internet users with physical disabilities to utilize Facebook.
HEME feels this is a milestone as Facebook is used by 500 million people in 70 different languages.
Never before have disabled individuals been able to neurally communicate and interact with a platform such as Facebook.
To learn more about HEME 's products check out their website and latest press releases under these links:
http://www.healthmedltd.com/
http://finance.yahoo.com/q/h?s=HEME.PK+Headlines
Here are some Facts on the healthcare Industry
HEME is operating in an industry that is constantly struggling in the U.S.
The need for healthcare services is ever growing in the States.
Below are some facts on the industry that could be very positive for HEME .
• President Obama has pledged 630 billion dollars to the healthcare industry in an attempt to overhaul, modernize and transform the industry. This means hospitals and healtcare firms will have more budget to spend for better services which could mean mroe revenue for HEME !
• In fact, it is expected that healthcare spending in general could reach 4.5 trillion by 2019.
• Healthcare Information Technology studies reveal 20% of healthcare professionals plan to incorporate the iPad into their practice. This could be huge for HEME considering that one of their software can be incorporated with the Ipad!
• According to Juniper Research, spending on mobile hardware, software and services across the global healthcare sector is set to rise to $2.7 billion by 2010.
• Analysts also reveal nearly $2.5 trillion in healthcare spent in 2009 was $134 billion more than the previous year
• According to Compass Intelligence, the U.S. market for health information technology will expand to $85 billion in 2014 from an estimated $73.1 billion this year, representing a 4.5 percent compound annual growth rate.
Clearly the industry in which HEME is operating is booming and there is an ever growing need for healthcare services!
HEME's coming off a 52 weeks Low!
Check out the chart on HEME below.
http://www.profitspi.com/stock-chart.aspx?id=HEME&ca=1024485986
You will notice that HEME just bounced off its 52 weeks low.
This could be a reversal sign that HEME is starting an uptrend!
The chart also shows that HEME traded above 30 cents which could leave a lot of upside potential!
Check out the latest press releases from HEME for the latest updates.
http://finance.yahoo.com/q/h?s=HEME.PK+Headlines
You will notice that there was several major announcements from HEME that could have been overlooked by Wall Street!
We think this could be a great opportunity for our members to look over HEME as a potential bounce and undervalued play.
We urge all our members to put HEME on their radar!
Next week could be huge for HEME!
**************************************************************************
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Pennystocksalerts.com's sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Pennystocksalerts.com or an offer or solicitation to buy or sell any security. Neither the owner of Pennystocksalerts.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters . Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit Pennystocksalerts.com. Pennystocksalerts.com make s no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Please be advised that Pennystocksalerts.com has entered into an agreement with Heiwa International Corp.which calls for payment of $100,000 cash to perform promotional and advertising services for a one week profile of Healthmed Services, Ltd.(OTC:HEME) which services include the issuance of this release and the other opinions that we release concerning HEME. Pennystocksalerts.com has not investigated the background of Heiwa International Corp., the hiring company. Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of Mercer Gold Corp. (OTC:HEME) of which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price. Pennystocksalerts.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution ex penses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Healthmed Services, Ltd.(OTC:HEME). Pennystocksalerts.com is owned by: Golden Dragon Media Inc, 770 sherbrooke ouest Suite 1700, H3A 1G1, Montreal (Quebec), Canada. Questions regarding this release may be sent to info@ Pennystocksalerts.com.
Notice of Stock Price Movements and Volatility
Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.
Notice of Affiliated and Non-Affiliated Newsletters
Pennystocksalerts.com regularly shares research with two affiliated newsletters (“Affiliated Newsletters”) whose services have been retained to profile Healthmed Services Ltd “HEME” during Pennystocksalerts.com’s profile period. Pennystocksalerts regularly coordinates the timing of the dissemination of its research reports with the two Affiliated Newsletters. It is also possible that other newsletters or profiles have been created by sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in Healthmed Services Ltd “HEME”.
Some of the content in this release contains f orward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look f orward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any f orward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirem ents in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.
Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. More information can be received from the advertised companies' website http://www.healthmedltd.com/ Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and t he Financial Industry Regulatory Authority ("FINRA") website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. Pennystocksalerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Pennystocksalerts.com has no obligation to update any of the information provided. Pennystocksalerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.
From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. Pennystocksalerts.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is bas ed on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.
This release may provide hyperlinks to third party websites or access to third party content. Pennystocksalerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Pennystocksalerts.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Pennystocksalerts.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Pennystocksalerts.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
Pennystocksalerts.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.
You agree to hold Pennystocksalerts.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. Pennystocksalerts.com disclaims all warranties of any kind, express or implied.
We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm.
